Catechol-based inhibitors of bacterial urease

Bioorg Med Chem Lett. 2019 May 1;29(9):1085-1089. doi: 10.1016/j.bmcl.2019.02.032. Epub 2019 Feb 27.

Abstract

Targeted covalent inhibitors of urease were developed on the basis of the catechol structure. Forty amide and ester derivatives of 3,4-dihydroxyphenylacetic acid, caffeic acid, ferulic acid and gallic acid were obtained and screened against Sporosarcinia pasteurii urease. The most active compound, namely propargyl ester of 3,4-dihydroxyphenylacetic acid exhibited IC50 = 518 nM andkinact/Ki = 1379 M-1 s-1. Inhibitory activity of this compound was better and toxicity lower than those obtained for the starting compound - catechol. The molecular modelling studies revealed a mode of binding consistent with structure-activity relationships.

Keywords: Cysteine; Irreversible inhibition; Nickel-dependent enzyme; Targeted covalent inhibitors; Urease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Catechols / chemistry
  • Catechols / pharmacology*
  • Enzyme Inhibitors / chemistry
  • Gene Expression Regulation, Bacterial / drug effects
  • Models, Molecular
  • Molecular Docking Simulation
  • Protein Conformation
  • Sporosarcina / enzymology*
  • Structure-Activity Relationship
  • Urease / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • Catechols
  • Enzyme Inhibitors
  • Urease

Supplementary concepts

  • Sporosarcina pasteurii